Effectiveness and patient safety of platelet aggregation inhibitors in the prevention of cardiovascular disease and ischemic stroke in older adults – a systematic review
Abstract Background Platelet aggregation inhibitors (PAI) are among the most frequently prescribed drugs in older people, though evidence about risks and benefits of their use in older adults is scarce. The objectives of this systematic review are firstly to identify the risks and benefits of their...
Main Authors: | Maren Meinshausen, Anja Rieckert, Anna Renom-Guiteras, Moritz Kröger, Christina Sommerauer, Ilkka Kunnamo, Yolanda V. Martinez, Aneez Esmail, Andreas Sönnichsen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-10-01
|
Series: | BMC Geriatrics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12877-017-0572-7 |
Similar Items
-
RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: D. H. Aynetdinova, et al.
Published: (2015-12-01) -
High residual platelet reactivity during dual antiplatelet therapy, found by optical aggregometry and the rate of atherothrombotic complications after coronary artery stenting in patients with ischemic heart disease in clinical practice
by: N. F. Puchinyan, et al.
Published: (2016-09-01) -
The Phenomenon of Clopidogrel High On-Treatment Platelet Reactivity in Ischemic Stroke Subjects: A Comprehensive Review
by: Adam Wiśniewski, et al.
Published: (2020-09-01) -
Resistencia al ácido acetil salicílico y al clopidogrel: una entidad clínica emergente Resistance to acetylsalicylic acid and to clopidogrel: an emergent clinical entity
by: José J Lugo, et al.
Published: (2008-08-01) -
Role of clopidogrel role in secondary prevention of ischemic stroke
by: K. S. Meshkova, et al.
Published: (2014-12-01)